IMPEDIMED LIMITED — Director's Dealing 2020

May 3, 2020

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: ImpediMed Limited ABN: 089 705 144

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Robert Graham
Date of last notice	30 April 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstancesgiving rise to the relevant interest.	RM Graham Pty LtdAstrusteeforR&JGrahamFamilySuperannuation FundDr Graham is a director of RM Graham PtyLtd and a beneficiary of the SuperannuationFund.
Date of change	01 May 2020
No. of securities held prior to change	Direct:773,186 Fully paid ordinary shares269,684 Options
Class	Ordinary shares
Number acquired	Indirect:773,186 Ordinary shares

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed	Direct:
	773,186 Ordinary shares
Value/Consideration	$30,154.25 ($0.039 per share)
Note: If consideration is non-cash, provide
details and estimated valuation
No. of securities held after change	Direct:
	269,684 Options
	Indirect:
	773,186 Fully paid ordinary shares
Nature of change	Off-market transfer from personal name to
Example: on-market trade, off-market trade,	superannuation fund
exercise of options, issue of securities under
dividend reinvestment plan, participation in
buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	No
If so, was prior written clearance provided to allow thetrade to proceed during this period?
If prior written clearance was provided, on what date wasthis provided?

Date of Notice: 04 May 2020

• See chapter 19 for defined terms.

Appendix 3Y Page 2